| Date | Form | Description | Docs | XBRL | Pages |
| 09/08/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/20 | 8-K | Current report filing |
|
25 | |
| 07/20/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 07/02/20 | DEF 14A | Definitive proxy statements |
|
46 | |
| 07/02/20 | 8-K | Current report filing |
|
6 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...